Placebo for bms-986435-01
CV029-1001
Phase 2 small_molecule active
Quick answer
Placebo for bms-986435-01 for Heart failure with preserved ejection fraction (HFpEF) is a Phase 2 program (small_molecule) at Bristol-Myers Squibb / Pfizer EEIG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb / Pfizer EEIG
- Indication
- Heart failure with preserved ejection fraction (HFpEF)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active